12 - 13 November 2021
Digital Event

Sponsorship and Exhibition

All Digital Industry Symposia

All Digital Symposia will be made available on the PAAM Digital 2021 platform.


Friday, 12 November 2021


Industry Symposium 1

11:30 – 12:45 (CET)

Nutricia: Latest real world data on the CMA journey; how can synbiotics reduce the health burden for infants and their families?

Chair: Rosan Meyer, UK

Infants/young children living with CMA have an increased health burden

Speaker: Kate Grimshaw, UK

Modulating the gut microbiota and improving immune outcomes

Speaker: Rebecca Stratton, UK

Case Studies

Speakers: Maria Eugenia Gervasoni, Argentina; Gemma Castillejo, Spain

Closing & Key messages

Chair: Rosan Meyer, UK





Industry Symposium 2

13:00 – 14:15 (CET)

DBV Technologies: Patients with peanut allergy: emerging solutions for a comprehensive management

Moderators: Montserrat Alvaro Lozano, Spain; Christian Vogelberg, Germany

Introduction: Current status of peanut allergy management in europe

Speaker: Montserrat Alvaro Lozano, Spain

Peanut immunotherapy: to a standardized approach

Speaker: Andre Knulst, The Netherlands

Peanut allergy management in a digital world

Speaker: Stephanie Dramburg, Germany

Conclusion

Speaker: Christian Vogelberg, Germany






Industry Symposium 3

14:30 – 15:45 (CET)

Nestlé Nutrition Institute: The link between early diet and food allergy

Moderator: Liam O’Mahony, Ireland

Introduction

Speaker: Liam O’Mahony, Ireland

Early interventions and long lasting effect on childhood allergies: The GINI study 20y results

Speaker: Monika Gappa, Germany

How do maternal diet and infant complementary feeding influence food allergy

Speaker: Carina Venter, USA

What do existing food allergy prevention studies tell us? What does the future hold?

Speaker: Kari Nadeau, USA

Live Q&A

Speakers: Liam O’Mahony, Ireland; Monika Gappa, Germany; Carina Venter, USA; Kari Nadeau, USA




Industry Symposium 4

16:00 – 17:15 (CET)

Sanofi Genzyme & Regeneron: Childhood asthma and the impact of type 2 inflammation

Opening remarks

Speakers: Leonard Bacharier, USA; Nikolaos Papadopoulos, Greece

The burden of childhood asthma

Speaker: Nikolaos Papadopoulos, Greece

Allergic asthma and type 2 inflammation in childhood

Speaker: Leonard Bacharier, USA

Panel Discussion: Type 2 inflammation in childhood asthma

Speakers: Leonard Bacharier, USA; Nikolaos Papadopoulos, Greece

Audience Q&A

Speakers: Leonard Bacharier, USA; Nikolaos Papadopoulos, Greece

Closing remarks

Speakers: Leonard Bacharier, USA; Nikolaos Papadopoulos, Greece





Saturday, 13 November 2021


Industry Symposium 5

10:00 – 11:15 (CET)

ALK: Raising paediatric awareness through growing evidence for allergy immunotherapy - optimise the treatment of children suffering from respiratory allergy

Introduction and setting the stage for paediatric allergic disease

Speaker: Priya Bansal, USA

Raising awareness of the disease burden in children and the preventive role of allergy immunotherapy

Speaker: Graham Roberts, UK

The growing evidence for SQ SLIT-tablet treatment in children - symptom control and sustained long-term efficacy

Speaker: Douglas Mack, Canada

From childhood to adolescence - providing patient-tailored education

Speaker: Marta Vazquez-Ortiz, UK

Panel discussion

Speakers: Priya Bansal, USA; Graham Roberts, UK; Douglas Mack, Canada; Marta Vazquez-Ortiz, UK



Industry Symposium 6

11:30 – 12:45 (CET)

Aimmune: Treating peanut allergy with oral immunotherapy: new data and practical experience. 

Moderator: Jonathan Hourihane, Ireland

Introduction

Speaker: Jonathan Hourihane, Ireland

Key phase 3 clinical data              

Speaker: Kirsten Beyer, Germany

Data update      

Speaker: Jonathan Hourihane, Ireland

Panel discussion: key learnings from practical experience

Speakers: Jonathan Hourihane, Ireland; Kirsten Beyer, Germany; Janet Beausoleil, USA

Live Q&A session

Speakers: Jonathan Hourihane, Ireland; Kirsten Beyer, Germany; Janet Beausoleil, USA





Industry Symposium 7

16:00 – 17:15 (CET)

Uriach: How can we improve the approach to treating chronic urticaria in children?

Moderator: Montserrat Álvaro, Spain

Introduction

Speaker: Montserrat Álvaro, Spain

Management of pediatric chronic urticaria patients: the gap between guidelines and practice

Speaker: Montserrat Álvaro, Spain

The prevalence and pathogenesis of chronic urticaria in children

Speaker: Stefania Arasi, Italy

The added value of rupatadine in pediatric chronic urticaria

Speaker: Vicky Xepapadaki, Greece

Discussion and Q&A

Speaker: Montserrat Álvaro, Spain




Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel